When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
PFE - Pfizer's Xtandi successful in late-stage study of Xtandi in metastatic prostate cancer
Pfizer Inc.
Pfizer (PFE-0.6%) and U.S. commercialization partner Astellas Pharma (OTCPK:ALPMF)(OTCPK:ALPMY) announce positive results from a Phase 3 clinical trial, ARCHES, evaluating XTANDI (enzalutamide) plus androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer.
More news on: Pfizer Inc., Astellas Pharma, Inc., Astellas Pharma, Inc. ADR, Healthcare stocks news,